University of Iowa Home Monitoring Program for COVID-19 Patients Working Well (Clinical Trial Sponsors Should Study the Model)

Jul 1, 2020 | COVID-19, Home Monitoring Program, News, University of Iowa

University of Iowa Home Monitoring Program for COVID-19 Patients Working Well (Clinical Trial Sponsors Should Study the Model)

University of Iowa Hospitals and Clinics have developed a program to monitor patients with COVID-19 from the comfort and safety of the individual’s homes. The “Home Treatment Program” designed by UI Health Care’s Home Treatment Team is led by a pair of Clinical Assistant Professors. Thus far, the program has evidenced success with a 99.7% recovery rate and only one death reported; the program has monitored 525 patients in May alone. TrialSite News takes great interest in such programs for purpose for how they could be adjusted for clinical trials remote monitoring programs.

The Program

Patients that are interested in the program are registered and enrolled, reports UI Health Care spokesperson Jennifer Brown in an email to the Daily Iowan. Ms. Brown reports that each patient receives a home monitoring kits with a blood pressure cuff and pulse oximeter; a staff members from the Home Treatment Team is in touch with these patients every 24 to 72 hours for an average of 15 days.

Brown reports that the University of Iowa maintains one of the best such COVID-19 home monitoring programs in the nation. To date, over 320 patients have healed and been discharged from home monitoring while just 9% were admitted into the hospital for impatient care. This record is compelling.

Lead Contacts

The program has been led by Andre Bryant, MD, and Bradley Manning, MD

Call to Action: For those interested in remote monitoring for patients during clinical trials, connect with these professors to learn more about the program.

0 Comments

Pin It on Pinterest